2-((5-(2-Methoxyphenyl)-4-methyl-4H-1,2,4-triazol-3-yl)thio)-N,N-diphenylacetamide

Catalog No. :
ACFFIO090
CAS No. :
333312-71-3
Molecular Formula :
C24H22N4O2S
Molecular Weight :
430.53

IUPAC Name:2-((5-(2-methoxyphenyl)-4-methyl-4H-1,2,4-triazol-3-yl)thio)-N,N-diphenylacetamide

2-((5-(2-Methoxyphenyl)-4-methyl-4H-1,2,4-triazol-3-yl)thio)-N,N-diphenylacetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$271.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((5-(2-Methoxyphenyl)-4-methyl-4H-1,2,4-triazol-3-yl)thio)-N,N-diphenylacetamide
IUPAC Name2-((5-(2-methoxyphenyl)-4-methyl-4H-1,2,4-triazol-3-yl)thio)-N,N-diphenylacetamide
MDL No.MFCD02228462
Molecular FormulaC24H22N4O2S
Molecular Weight430.53
SMILESO=C(N(C1=CC=CC=C1)C2=CC=CC=C2)CSC3=NN=C(C4=CC=CC=C4OC)N3C
InChI KeyZFEQGSAXJBKYKV-UHFFFAOYSA-N
Synonym2-[[5-(2-methoxyphenyl)-4-methyl-1,2,4-triazol-3-yl]sulfanyl]-N,N-diphenylacetamide
CAS No.333312-71-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACFFIO090 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFFIO090 route product structure diagram
    ACFFIO090333312-71-3
Inquiry

2. ACFFIO090 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHQJT902 route compound structure diagram
    ACHQJT9025428-43-3 In Stock
  4. Then
  5. ACFFIO090 route product structure diagram
    ACFFIO090333312-71-3
Inquiry

Comments (0)